Subsequent Development of Epithelial Ovarian Cancer After Ovarian Surgery for Benign Ovarian Tumor: A Population-Based Cohort Study
- PMID: 32606989
- PMCID: PMC7308129
- DOI: 10.2147/CLEP.S199349
Subsequent Development of Epithelial Ovarian Cancer After Ovarian Surgery for Benign Ovarian Tumor: A Population-Based Cohort Study
Abstract
Purpose: The goal of the current study is to determine the risk of subsequent development of epithelial ovarian cancer (EOC) in women after ovarian surgery for benign ovarian tumors.
Patients and methods: We conducted the nationwide population-based historic cohort study using the National Health Insurance Research Database (NHIRD) of Taiwan. Eleven thousand six hundred twenty women who underwent ovarian surgery for ovarian benign diseases were analyzed. The collected data included age, types of ovarian surgery, medical history by Charlson comorbidity index (CCI), infertility (yes/no), pelvic inflammatory disease (PID) (yes/no), tubal ligation (yes/no), total/subtotal hysterectomy (TH/STH) (yes/no), and endometrioma (yes/no). We used the Kaplan-Meier method and the Log-rank test to evaluate the risk factors. Cox proportional hazard methods were used to evaluate risk factors for the subsequent development of EOC. Multivariate analysis using Cox stepwise forward regression was conducted for the covariate selected in univariate analysis. Hazard ratio (HR) and 95% confidence interval (CI) were calculated using the Wald test.
Results: Subsequent EOC incidence rate (IR, incidence per 10,000 person-years) of women after ovarian surgery for benign ovarian tumors was 2.98. Separating into four groups based on different age, IR of EOC was 1.57 (<30 years), 4.71 (30-39 years), 3.59 (40-49 years) and 0.94 (≥50 years), respectively. Univariate and multivariate analyses identified only high level of CCI (≥2 or more) as an independent risk factor for subsequent development of EOC in women after ovarian surgery for benign ovarian tumors (HR 59.17, 95% CI 7.50-466.80 in women with CCI level of 2 and HR 190.68, 95% CI 24.33-2494.19, in women with CCI level ≥3, respectively).
Conclusion: Our results, if confirmed, suggest that women with other comorbidities (CCI) should be well informed that they may have a higher risk of subsequent development of EOC when ovarian surgery is planned even though the final pathology showed a benign ovarian tumor.
Keywords: benign ovarian tumor; cohort study; epidemiology; epithelial ovarian cancer; ovarian surgery; risk.
© 2020 Huang et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures
Similar articles
-
The Risk of Epithelial Ovarian Cancer of Women With Endometriosis May be Varied Greatly if Diagnostic Criteria Are Different: A Nationwide Population-Based Cohort Study.Medicine (Baltimore). 2015 Sep;94(39):e1633. doi: 10.1097/MD.0000000000001633. Medicine (Baltimore). 2015. PMID: 26426652 Free PMC article.
-
An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosis.BMC Cancer. 2014 Nov 18;14:831. doi: 10.1186/1471-2407-14-831. BMC Cancer. 2014. PMID: 25403543 Free PMC article.
-
Endometriosis and the subsequent risk of epithelial ovarian cancer.Taiwan J Obstet Gynecol. 2014 Dec;53(4):530-5. doi: 10.1016/j.tjog.2014.04.025. Taiwan J Obstet Gynecol. 2014. PMID: 25510696
-
[Analysis of perioperative complications and influencing factors of complications in 1 000 cases of robotic gynecological surgery].Zhonghua Fu Chan Ke Za Zhi. 2021 May 25;56(5):341-348. doi: 10.3760/cma.j.cn112141-20201217-00896. Zhonghua Fu Chan Ke Za Zhi. 2021. PMID: 34034421 Chinese.
-
Risk of epithelial ovarian cancer Type I and II after hysterectomy, salpingectomy and tubal ligation-A nationwide case-control study.Int J Cancer. 2021 Oct 15;149(8):1544-1552. doi: 10.1002/ijc.33714. Epub 2021 Jul 7. Int J Cancer. 2021. PMID: 34152012
Cited by
-
Does any serum marker predict the ovarian endometrioma accompanied with or without deep infiltrative endometriosis?J Chin Med Assoc. 2020 Sep;83(9):797-798. doi: 10.1097/JCMA.0000000000000381. J Chin Med Assoc. 2020. PMID: 32649416 Free PMC article. No abstract available.
-
miRNA Expression Profiles in Ovarian Endometriosis and Two Types of Ovarian Cancer-Endometriosis-Associated Ovarian Cancer and High-Grade Ovarian Cancer.Int J Mol Sci. 2023 Dec 14;24(24):17470. doi: 10.3390/ijms242417470. Int J Mol Sci. 2023. PMID: 38139300 Free PMC article.
References
-
- Vergote I, Coens C, Nankivell M, et al. EORTC; MRC CHORUS study investigators. Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials. Lancet Oncol. 2018;19(12):1680–1687. doi:10.1016/S1470-2045(18)30566-7 - DOI - PubMed
LinkOut - more resources
Full Text Sources